IP Library Granted Patent US 10,501,784
Granted Patent B2
US 10,501,784 · App. 15/237,266 · Granted Dec 10, 2019

Sequence amplification with linear primers

Inventors: Kai Lao (Pleasanton, CA); Neil Straus (Emeryville, CA); Nanlan Xu (Danville, CA)
Assignee: Life Technologies Corporation
C12Q1/6853C12Q1/6844C12Q1/6848C12Q2600/158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,501,784
App. No.
15/237,266
Granted
Dec 10, 2019
Kind
B2
Abstract

The present disclosure relates to the amplification of target nucleic acid sequences for various sequencing and/or identification techniques. The use of these primers, as described herein, allows for the reduction in the amplification of nonspecific hybridization events (such as primer dimerization) while allowing for the amplification of the target nucleic acid sequences.

Claims (27)

1. A method of amplifying a nucleic acid sequence, comprising:

a) generating a plurality of cDNA target sequences by a performing reverse transcription reaction on a plurality of RNA;

b) hybridizing the plurality of cDNA target sequences with a plurality of first linear primers which contain (i) a terminal 3′ region having a first unconstrained random sequence and (ii) a 5′ region having a first universal sequence,

wherein the first unconstrained random sequences of the terminal 3′ region include inosine, adenosine, guanosine, and cytidine, and the first random sequences exclude thymidine,

wherein the plurality of the first linear primers include different random sequences,

wherein the random sequences hybridize to a sequence of the plurality of cDNA target sequences, and

wherein the plurality of the first linear primers include the same universal sequence which does not hybridize to the plurality of cDNA target sequences; and

c) forming a plurality of extended linear primer products by extending the first linear primers that are hybridized to the plurality of cDNA target sequences;

d) hybridizing the plurality of the extended linear primer products to a plurality of second linear primers which contain (i) a terminal 3′ region having a second unconstrained random sequence and (ii) a 5′ region having a second universal sequence,

wherein the second random unconstrained sequences of the terminal 3′ region include inosine, adenosine, guanosine, and cytidine, and the second random sequences exclude thymidine,

wherein the plurality of the second linear primers include different random sequences, and

wherein the random sequences hybridize to a portion of the extended linear primer products,

wherein the plurality of the second linear primers include the same universal sequence as the universal sequence in the first linear primers; and

e) forming a plurality of double-extended linear primer products by extending the plurality of second linear primers that are hybridized to the plurality of the extended linear primer products.

2. The method of claim 1 , further comprising: forming a plurality of hairpin structures by intramolecular hybridizing the plurality of double-extended linear primer products in step (e).

3. The method of claim 1 , further comprising: sequencing the double-extended linear primer products in step (e).

4. The method of claim 1 , further comprising: forming amplification products by amplifying the plurality of double-extended linear primer products of step (e) in a single primer amplification reaction with a plurality of amplification primers that hybridize to the first or the second universal sequence regions of the plurality of double-extended linear primer products.

5. The method of claim 4 , further comprising: forming a plurality of hairpin structures by intramolecular hybridizing the amplification products.

6. The method of claim 4 , further comprising: sequencing the amplification products.

7. The method of claim 1 , further comprising: forming amplification products by amplifying the plurality of double-extended linear primer products of step (e) in an exponential amplification reaction with (i) a plurality of amplification primers that hybridize to the first universal sequence regions of the plurality of double-extended linear primer products, and (ii) a plurality of amplification primers that hybridize to the second universal sequence regions of the plurality of double-extended linear primer products.

8. The method of claim 7 , further comprising: forming a plurality of hairpin structures by intramolecular hybridizing the amplification products.

9. The method of claim 7 , further comprising: sequencing the amplification products.

10. The method of claim 1 , wherein the first and second random sequences in the terminal 3′ regions of the first and second linear primers is 4-12 nucleotides in length.

11. The method of claim 1 , wherein the plurality of RNA is isolated from a single cell.

12. The method of claim 1 , wherein the plurality of RNA is isolated from fewer than 10 cells.

13. The method of claim 1 , wherein the plurality of RNA is isolated from fewer than 100 cells.

14. The method of claim 1 , wherein the plurality of RNA is isolated from a tumor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2017
From: LAO, KAI QIN; XU, NAN LAN; STRAUS, NEIL A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 043235/0707 →
Continuity (5)
Continuation 14101226 · Dec 9, 2013
Continuation 13333419 · Dec 21, 2011
Continuation 12428196 · Apr 22, 2009
Provisional Application 61125279 · Apr 23, 2008
Related Publication 20170107567A1 · Apr 20, 2017